Impact/Interest of a Collective Prevention Intervention in Sexual and Emotional Health (Impex)

May 27, 2025 updated by: Pole Sante Grace de Dieu

Impact/Interest of a Collective Prevention Intervention in Sexual and Emotional Health Among High School Students in Lower Normandy

Main objective To measure the effects of a group prevention intervention on the sexual and affective knowledge of high school students in the Basse-Normandie region.

Secondary objective Take stock of what is known about the sexual and emotional health of teenagers.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

With the average age at first sexual intercourse in France being 17.6 for girls and 17.2 for boys, according to the 2010 health barometer, sexuality education and prevention seem essential at this age, and upstream.

An Australian qualitative study of young men aged 18 to 24 revealed that the main obstacles to discussing sexual health in general practice included the possibility of embarrassment and the fact that the subject was private. Most said they would only talk to their doctor about a sexual problem if it was very important or urgent: if not, they would prefer to wait for the doctor to initiate the subject.

Sexual health prevention initiatives are therefore essential outside the general practitioner's office, and have been shown to be effective in high schools. This is why the PSLA de la Grâce de Dieu has initiated sexual and emotional health prevention initiatives for students at a high school in Caen.

It therefore seemed interesting to assess these students' knowledge of sexual and emotional health before the PSLA's intervention in the amphitheatre with the students, and then after the intervention, in order to find out whether this large-scale prevention action had an impact on these students' knowledge, in the short and medium term.

Study Type

Observational

Enrollment (Actual)

450

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Caen, France, 14000
        • PSLA GDD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Intervention in a school setting. This intervention is part of a biology course (Life and Earth Sciences). It is a class project. Theoretically, all high school students are recruited.

Description

Inclusion Criteria:

  • school students in the 2023-2024 school year

Exclusion Criteria:

  • A newsletter was sent to the school's head teachers, the students' parents and the students themselves, informing them of the possible use of the data for research purposes, and the possibility of objecting. The principal teachers provided information on the non-obligation to respond during the distribution of the questionnaires. Students who did not respond to the questionnaire were therefore not included.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of knowledge improvement between before and after the intervention
Time Frame: 1 year
the accuracy of correct answers between before and after intervention
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Pole Sante Grace de Dieu

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2024

Primary Completion (Actual)

April 30, 2024

Study Completion (Actual)

April 30, 2024

Study Registration Dates

First Submitted

April 30, 2024

First Submitted That Met QC Criteria

May 2, 2024

First Posted (Actual)

May 6, 2024

Study Record Updates

Last Update Posted (Actual)

May 31, 2025

Last Update Submitted That Met QC Criteria

May 27, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 20240205

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Public Health

Clinical Trials on questionary

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gabon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe